Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study.

Bourin, Michel S; Severus, Emanuel; Schronen, Juan P; Gass, Peter; Szamosi, Johan; Eriksson, Hans; Chandrashekar, Hongally

Bourin, Michel S; Severus, Emanuel; Schronen, Juan P; Gass, Peter; Szamosi, Johan; Eriksson, Hans; Chandrashekar, Hongally.

Afiliación

Bourin MS; Department of Pharmacology, Faculty of Medicine, University of Nantes, 98, rue Joseph Blanchart, 44100 Nantes, France.
Severus E; Department of Psychiatry and Psychotherapy, Technical University of Dresden, Dresden, Germany.
Schronen JP; Cape Trial Centre, Cape Town, South Africa.
Gass P; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Szamosi J; AstraZeneca R&D, Södertälje, Sweden.
Eriksson H; AstraZeneca R&D, Södertälje, Sweden.
Chandrashekar H; Bangalore Medical College and Research institute, Victoria Hospital, Bangalore, India.

Int J Bipolar Disord ; 2: 14, 2014.

Article en En | MEDLINE | ID: mdl-25505693

Palabras clave

Bipolar mania; Lithium; Quetiapine XR

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Int J Bipolar Disord Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google